Tag Archives: Blood Vessels

Caring Communities against Thalassaemia

Posted on by

Thalassaemia ….., this word may still seem strange to some, but now increasing numbers of people with Thalassaemia in Indonesia. Thalassaemia itself is a blood disorder caused by insufficient production of hemoglobin (red blood cells) caused by the disruption in the process of chain formation of red blood cells because of damage to genes in the body. So for people with Thalassaemia, the only way to increase the amount of hemoglobin (Hb) in the blood is by way of a blood transfusion either continuously or from time to time depending on the type experienced Thalassaemia.

Thalassaemia is a genetic disorder, so it can be passed down from parent to child, although not to the whole child. For couples who turns each have a gene carrier (carrier) Thalassaemia, then it will have the possibility to have children who are patients of Thalassaemia as much as 25%. For more details can be viewed at the following chart:

According to the WHO in 1994, the number of people who have a carrier or carriers of Thalassaemia genes in the world reached 4.5%, or about 250 million people, of which 300 thousand children suffering from Thalassaemia are born each year and of that number about 60-70 thousand of which are β Thalassaemia major patients who require blood transfusions continuously since the diagnosis even though the baby. And the number is increasing so that based on data from WHO, the number of carriers in 2001 represented 7% of the total world population.

So as to further enhance public awareness of the disease Thalassaemia, then on Tuesday, December 29, 2009 held at Jakarta, held a press conference event on The Thalassaemia Ambassador or ambassador Thalasaemia. Thalassaemia ambassador program is a joint program of PT. Novartis Indonesia with Orange for Kids organization which aims to provide education from patient to patient, thereby increasing the life expectancy of patients with Thalassaemia. In this program, which is also an ambassador Thalassaemia Thalassaemia patients will provide education to the other patients to improve adherence to undergo blood transfusions and iron chelation also take medication regularly and motivate patients to continue to have a zest for life and have a good quality of life as well as useful in everyday life.

Concern for Thalassaemia disease and the sufferer can be done by any person, whether through education about the disease and by the way do not stay away from the sufferer.

Studying Diabetes through the Diabetes EduCenter

Posted on by

Diabetes is a disease in which the amount of insulin in the body decreases or becomes insensitive to convert sugar into energy, so the sugar levels in the body becomes high. With the presence of hyperglycemia (high glucose levels in the blood) then this can cause various complications both in the short or long term that can interfere with quality of life for diabetics. Complications that may arise in the long run are: the failure of kidney function, damage to the retina of the eye, neurological disease that usually attacks in the legs and cardiovascular disease that affects the heart and blood vessels.

Global campaigns on important diabetes care are to improve public awareness of diabetes, including ways to prevent it. For Indonesia itself education on all lines and levels of society about diabetes is important to do, considering the number of diabetics growing from year to year and also to prevent the prediabetes to refrain from becoming diabetic.

This educational program is the responsibility of all those involved from the public, patients, physicians, hospitals, drug manufacturers and the government. Provision of information from fellow diabetic patients is also expected to help each patient to better understand the disease, it is because sometimes patients still feel free to ask more when you want to physicians.

Causes and Prevention of Venous Thromboembolism

Posted on by

Causes of Venous Thromboembolism

Based on Virchow triad, venous thrombosis occurs due to the slowdown in the flow / static blood, damage to blood vessel walls, and the increased tendency of blood clots (hiperkoagubilitas). If any of these three factors was not found (no), venous thrombosis did not occur.

In Europe, the presence of blood clots in the veins is the cause of more deaths than AIDS, breast cancer, prostate cancer, and accidents combined. In addition, venous thromboembolism caused death of more than 500,000 people in Europe each year.

A Difficult Diagnosis

Clinical diagnosis of venous thromboembolism is rather difficult because the signs and symptoms are not specific for deep venous thrombosis and pulmonary embolism. Estimated clinical use signs, symptoms, and risk factors for mengkatogerikan patients who have a low probability of experiencing venous thromboembolism, moderate or high normal use.

Prevention of Venous Thromboembolism

Guidelines of the American College of Chest Physicians (ACCP) recommend giving anti-coagulants in high-risk group. For more than 70 years, anti-coagulants have been used to prevent and deal with a potentially fatal blood clots. Currently an oral anticoagulant with a mechanism inhibiting factor Xa has been launched. With consumption once a day, Rivaroxaban, the EU commission has allowed the use of Rivaroxaban as therapy of venous thromboembolism in adult patients who underwent hip or knee surgery. Rivaroxaban is being developed currently use for patients who need preventive treatment of blood clotting. With the direct inhibition of factor Xa in the blood clotting process, Rivaroxaban can regulate the amount of thrombin with no deter tromnin work itself.